10-K: Expion360 Inc. Details Capital Stock, Warrants, and Potential Anti-Takeover Measures in Annual Report

Expion360's 10-K filing outlines the company's capital structure, warrant issuances, and measures that could deter a change in control.

Summary

• Expion360's 10-K filing details the company's capital stock, consisting of 200,000,000 shares of common stock and 20,000,000 shares of preferred stock, both with a par value of $0.001 per share.
• Common stockholders are entitled to one vote per share and have rights to dividends and assets upon liquidation.
• As of December 31, 2024, all $290.00 warrants had been exercised or expired.
• The company has issued warrants to purchase common stock at exercise prices of $332.00 and $910.00 (later amended to $450.00).
• In August 2024, Expion360 sold common units and pre-funded units, including Series A and Series B warrants, in a public offering.
• Each Series A Warrant was exercisable at any time or times beginning on the first trading day following the Company's notice to the Series A Warrant holders of Stockholder Approval, and will expire five years from such date.
• Each Series A Warrant is exercisable at an initial exercise price of $24.00 per share of Common Stock (post-Reverse Stock Split).
• Each Series B Warrant was exercisable immediately upon issuance at an exercise price of $0.10 per share.
• On January 3, 2025, the Company issued pre-funded warrants to purchase up to 574,193 shares of Common Stock to certain institutional investors.
• The offering price per Pre-Funded Warrant was $2.479.
• Each Common Warrant was exercised in full for one share of Common Stock at an exercise price of $2.36 per share.
• Nevada law and the company's bylaws include provisions that may delay or prevent a change in control, including a control share acquisition act and a combination with interested stockholders statute.
• The company's articles of incorporation include a mandatory forum provision for certain litigation.
• As of March 25, 2025, there were 3,144,468 shares of the registrant's common stock outstanding.

Sentiment

Score: 5

Explanation: The document is largely factual, presenting information about the company's capital structure and governance. The inclusion of risk factors and potential anti-takeover measures tempers any positive sentiment.

Positives

• The company has an effective registration statement for the resale of shares issuable upon exercise of the $332.00 warrants.
• The company has the ability to adjust the exercise price and number of shares underlying the Series A Warrants upon the company's issuance of Common Stock or Common Stock equivalents at a price per share that is less than the exercise price of the Series A Warrants.
• The company has a transfer agent and registrar for its common stock, Pacific Stock Transfer Company.
• The company's common stock has been traded on Nasdaq under the symbol XPON since April 1, 2022.

Negatives

• The Reverse Stock Split cash true-up payment provision in the Series A Warrants we sold in the August 2024 Public Offering may have a material adverse impact on our financial condition, may impede our ability to raise additional capital, and may discourage an acquisition of us by a third party.

Risks

• The exercise of outstanding warrants may result in a substantial increase in the number of shares of our common stock that are outstanding.
• The Series A Warrants and Series B Warrants may have an adverse effect on the market price of our common stock and make it more difficult to effect a business combination.
• The Reverse Stock Split cash true-up payment provision in the Series A Warrants we sold in the August 2024 Public Offering may have a material adverse impact on our financial condition, may impede our ability to raise additional capital, and may discourage an acquisition of us by a third party.
• The control share acquisition act is applicable only to shares of Issuing Corporations as defined by the Nevada law.
• The Nevada Combination with Interested Stockholders Statute may also have an effect of delaying or making it more difficult to effect a change in control of us.

Future Outlook

The company aims to provide additional capacities to the expanding electric forklift and industrial material handling markets.

Industry Context

The document provides insight into Expion360's positioning within the lithium battery market and its efforts to capitalize on the shift from lead-acid batteries.

Comparison to Industry Standards

• The document mentions competitors like Relion, Dragonfly Energy, Renogy, and Dakota Lithium, highlighting the competitive landscape of the lithium-ion battery market.
• The document compares Expion360's batteries to lead-acid batteries, noting their superior capacity, lifespan, and charging cycles.
• The document states that Expion360's batteries utilize lithium iron phosphate and therefore are expected to have a lifespan of approximately 12 years three to four times that of certain lead-acid batteries and ten times the number of charging cycles.

Management Changes

Legal Proceedings

• On September 6, 2024, the Company received a staff determination from The Nasdaq Listing Qualifications Department of Nasdaq to delist its Common Stock from Nasdaq.
• On September 12, 2024, the Company requested an appeal hearing on the Staff Determination from a Hearings Panel (the Panel) by filing a hearing request with Nasdaq pursuant to the procedures set forth in the Nasdaq Listing Rules, staying the delisting of the Company's common stock pending the Panel's decision
• Upon successful completion of the Reverse Stock Split, the Company received a letter from the Nasdaq Office of General Counsel on October 23, 2024, advising the Company that it had regained compliance with the minimum bid price continued listing requirements in Listing Rule 5550(a)(2) and that the Company is therefore in compliance with Nasdaq's listing requirements.

Stakeholder Impact

• The exercise of outstanding warrants may result in a substantial increase in the number of shares of our common stock that are outstanding and therefore materially dilute the ownership percentage of currently outstanding shares of common stock.
• The Series A Warrants and Series B Warrants may have an adverse effect on the market price of our common stock and make it more difficult to effect a business combination.
• The Reverse Stock Split cash true-up payment provision in the Series A Warrants we sold in the August 2024 Public Offering may have a material adverse impact on our financial condition, may impede our ability to raise additional capital, and may discourage an acquisition of us by a third party.

Next Steps

• The company intends to continue to focus on its sales and distribution channels to develop existing customer relationships and grow its customer base.
• The company plans to continue operating its warehousing out of its Redmond, Oregon headquarters and Elkhart, Indiana locations.
• The company plans to renew the commercial line of credit in April 2025.
• The company plans to manufacture lithium-ion batteries in the future.

Key Dates

Keywords

warrants, common stock, preferred stock, capital stock, reverse stock split, anti-takeover, Nevada law, Series A warrants, Series B warrants, Expion360